• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight

cafead

Administrator
Staff member
  • cafead   Nov 10, 2022 at 10:22: PM
via After a trial this week, a Boston federal jury has ordered Eli Lilly to pay rival Teva $176.5 million for infringing three patents covering the latter's migraine prevention drug, Ajovy, Reuters reports.

article source